These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28249081)

  • 1. Management of Type 2 Diabetes in 2017: Getting to Goal.
    Reusch JE; Manson JE
    JAMA; 2017 Mar; 317(10):1015-1016. PubMed ID: 28249081
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease.
    Shehadeh N; Raz I; Nakhleh A
    Cardiovasc Diabetol; 2018 Aug; 17(1):117. PubMed ID: 30134893
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tough glucose reduction necessary in newly diagnosed diabetes].
    Rydén M
    Lakartidningen; 2010 Nov 10-16; 107(45):2810-4. PubMed ID: 21179867
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin useful in combination with exogenous insulin.
    Hanuschak LN
    Diabetes Care; 1996 Jun; 19(6):671-2. PubMed ID: 8725873
    [No Abstract]   [Full Text] [Related]  

  • 5. Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetes.
    Vora J; Bain SC; Damci T; Dzida G; Hollander P; Meneghini LF; Ross SA
    Diabetes Metab; 2013 Feb; 39(1):6-15. PubMed ID: 23022130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
    Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
    Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
    Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?
    Zenari L; Marangoni A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():17-25. PubMed ID: 24034516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of type 2 diabetes: new or previous agents, how to choose?].
    Halimi S
    Presse Med; 2013 May; 42(5):861-70. PubMed ID: 23643613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing postprandial glucose levels in patients with diabetes.
    Tenzer-Iglesias P; Brunton S
    J Fam Pract; 2008 Jan; 57(1 Suppl Managing):S17-24. PubMed ID: 18662529
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical treatment of type 2 diabetes. Recommendations for good practice].
    Diabetes Metab; 2007 Jan; 33(1 Pt 2):1S26-105. PubMed ID: 17499188
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin: an antihyperglycemic drug for non-insulin-dependent diabetes mellitus.
    Kupecz D
    Nurse Pract; 1995 Jul; 20(7):70-2. PubMed ID: 7675343
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
    Niessner A; Tamargo J; Koller L; Saely CH; Schmidt TA; Savarese G; Wassmann S; Rosano G; Ceconi C; Torp-Pedersen C; Kaski JC; Kjeldsen KP; Agewall S; Walther T; Drexel H; Lewis BS
    Eur Heart J; 2018 Jun; 39(24):2274-2281. PubMed ID: 29126266
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management strategies for type 2 diabetes.
    Cefalu WT; Urquhart S
    JAAPA; 2007 Dec; Suppl():9-14. PubMed ID: 18217246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic control in diabetes.
    Herman W
    Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of SGLT-2 inhibitors in the treatment of type 2 diabetes].
    Rupprecht H
    MMW Fortschr Med; 2015 Jan; 157(1):55-8. PubMed ID: 25743304
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing hyperglycaemia.
    Curtis S
    Br J Gen Pract; 2008 Oct; 58(555):729; authore reply 729-30. PubMed ID: 18826786
    [No Abstract]   [Full Text] [Related]  

  • 19. [Not Available].
    Zulewski H
    Ther Umsch; 2017; 74(8):411-416. PubMed ID: 29461143
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLira.
    Wilding JP; Bain SC
    Diabet Med; 2016 Jul; 33(7):864-76. PubMed ID: 26525806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.